TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31714636

Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors
Number of subjects: 81403

Group type: COMPARATOR
Intervention: HMGCR, APOB, NPC1L1 (statins, ezetimibe, mipomersen)
Number of subjects: 81403
Study: 30106523

Group type: EXPERIMENTAL
Intervention: Oral health promotion program in primary schools
Number of subjects: 740

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Oral health promotion program in primary schools (for high socio-economic status)
Number of subjects: 740

Group type: EXPERIMENTAL
Intervention: Oral health promotion program in primary schools (for low socio-economic status)
Number of subjects: 740
Study: 26872721

Group type: EXPERIMENTAL
Intervention: Chicory inulin (10g daily for 2 months)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 24063291

Group type: EXPERIMENTAL
Intervention: 22-session group-based intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: No-intervention, assessment-only control condition
Number of subjects: 92
Study: 22180317

Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment with a spectral range of 500-670 and 870-1,200 nm, fluence range of 34-70 J/cm(2), 10 mm × 15 mm spot, pulse width of 10 or 100 mseconds, and 5°C contact cooling.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pulsed Dye Laser (PDL) treatment at 595 nm, fluence range of 8.1-14.5 J/cm(2), 10 or 7 mm spot, pulse width of 10 or 40 mseconds, with Zimmer air cooling and ultrasound gel.
Number of subjects: 16
Study: 20838337

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: On-pump coronary artery bypass surgery
Number of subjects: 0
Study: 17379050

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 15531021

Group type: EXPERIMENTAL
Intervention: Individualized moderate intensity physical training program
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 21
Study: 12398964

Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Baseline MLC-1 increase
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: MLC-1
Number of subjects: 218
Study: 10805552

Group type: EXPERIMENTAL
Intervention: Different suture materials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous closure techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual surgeons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular audit with feedback to individual surgeons
Number of subjects: 0
Study: 8576655

Group type: EXPERIMENTAL
Intervention: 200 micrograms of terbutaline
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 10 mg of sodium cromoglycate
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 100 micrograms of budesonide
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 2338416

Group type: EXPERIMENTAL
Intervention: FCE 22101 intravenously at a dose of 250 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: FCE 22101 with imipenem/cilastatin
Number of subjects: 8

Group type: COMPARATOR
Intervention: FCE 22101 alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: FCE 22101 with cilastatin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: FCE 22891 orally at a dose of 500 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 8
Study: 393518

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Alprenolol
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: All three drugs
Number of subjects: 105
Study: 30100574

Group type: EXPERIMENTAL
Intervention: Endobronchial valves (EBV)
Number of subjects: 49
Study: 28689741

Group type: EXPERIMENTAL
Intervention: MCT oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coconut oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vegetable oil (control)
Number of subjects: 0
Study: 26493675

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 1180
Study: 24115827

Group type: EXPERIMENTAL
Intervention: LAM + ADV therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: ETV monotherapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 21887230

Group type: EXPERIMENTAL
Intervention: G‐CSF treatment (2.5, 5, or 10 μg/kg body weight) for 5 consecutive days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: G‐CSF treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: G‐CSF treatment in combination with routine IV thrombolysis
Number of subjects: 20
Study: 18719948

Group type: EXPERIMENTAL
Intervention: Opioid application
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nasal O2 insufflation (4 l/min)
Number of subjects: 46
Study: 15795131

Group type: EXPERIMENTAL
Intervention: Players deriving pleasure from larger payoffs in the ultimatum game
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Players deriving pleasure from larger payoffs in the dictator game
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Players deriving greater pleasure from fairness
Number of subjects: 0
Study: 12653802

Group type: EXPERIMENTAL
Intervention: Standard skin prick test (SPT) method
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Modified skin prick test (SPT) method
Number of subjects: 21
Study: 11563404

Group type: EXPERIMENTAL
Intervention: 10 mg ketoprofen administered locally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30 mg ketoprofen administered locally
Number of subjects: 0

Group type: COMPARATOR
Intervention: 25 mg oral capsule of ketoprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral administration of 10 mg ketoprofen
Number of subjects: 0
Study: 8712443

Group type: EXPERIMENTAL
Intervention: Vasoconstriction (isoflurane concentration reduced)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vasodilation (sufficient isoflurane to prevent vasoconstriction)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Forced-air warming
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Core temperature increase
Number of subjects: 8
Study: 10149784

Group type: EXPERIMENTAL
Intervention: Cuff neosalpingostomy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Bruhat neosalpingostomy
Number of subjects: 34
Study: 7128191

Group type: EXPERIMENTAL
Intervention: 200 mg meptazinol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 g paracetamol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 28241215

Group type: EXPERIMENTAL
Intervention: Internet‐delivered, physiotherapist‐prescribed home exercise and pain‐coping skills training (PCST)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Internet‐based educational material
Number of subjects: 148
Study: 25163902

Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis (DBT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Full Field Digital Mammography (FFDM)
Number of subjects: 107
Study: 23306584

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (≈3 ml/kg) combined with extracorporeal CO2 elimination
Number of subjects: 79

Group type: COMPARATOR
Intervention: ARDSNet strategy (≈6 ml/kg) without the extracorporeal device
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study: 21596011

Group type: EXPERIMENTAL
Intervention: Alcohol condition (target BAC = .08%; n = 22)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Placebo condition (n = 20)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Nonalcoholic control condition (n = 20)
Number of subjects: 62
Study: 18281231

Group type: EXPERIMENTAL
Intervention: Outpatient rehabilitation training (Group A)
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation training (Group B)
Number of subjects: 531

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 531
Study: 17159021

Group type: EXPERIMENTAL
Intervention: Massage therapy (twice‐weekly sessions of standard Swedish massage in weeks 1‐4 and once‐weekly sessions in weeks 5‐8)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 68
Study: 15615552

Group type: EXPERIMENTAL
Intervention: Percutaneous EVR using 14-F to 20-F sheaths
Number of subjects: 95
Study: 11281248

Group type: EXPERIMENTAL
Intervention: Dieting and exercising to lose an average of 0.5 kg/week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 9059567

Group type: EXPERIMENTAL
Intervention: L-arginine (30 g in 50 ml of normal saline over 30 minutes) with L-NAME (90 micrograms/kg in 50 ml of normal saline)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Glucose (0.33 g/kg body weight in a bolus) with L-NAME (90 micrograms/kg in 50 ml of normal saline)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glucose (0.33 g/kg body weight in a bolus) with saline
Number of subjects: 14

Group type: COMPARATOR
Intervention: L-NAME (90 micrograms/kg in 50 ml of normal saline) alone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline alone
Number of subjects: 14
Study: 7956277

Group type: EXPERIMENTAL
Intervention: Dopamine infusion (5 micrograms/kg/min i.v.)
Number of subjects: 33
Study: 2885637

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen 20 mg daily for 5 years
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Tamoxifen for the treatment of first relapse (Control)
Number of subjects: 1312
Study: 31959395

Group type: EXPERIMENTAL
Intervention: Reconstructed with free fibula flap (n=11)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Obturator prosthesis (n=13)
Number of subjects: 24
Study: 27862718

Group type: EXPERIMENTAL
Intervention: Modified open surgery with catheter fixation (MOS-F group)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Modified open surgery (MOS group)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Traditional open surgery (TOS group)
Number of subjects: 152
Study: 26386578

Group type: EXPERIMENTAL
Intervention: Intravenous MDCO-157 75 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intravenous MDCO-157 150 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intravenous MDCO-157 300 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Oral Clopidogrel 300 mg
Number of subjects: 33
Study: 25419549

Group type: EXPERIMENTAL
Intervention: Vildagliptin 50mg bid
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318
Study: 22114101

Group type: EXPERIMENTAL
Intervention: Exercise training and usual care
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 2331
Study: 20738314

Group type: EXPERIMENTAL
Intervention: Physiological sex steroid replacement (pSSR) - transdermal oestradiol 100 μg daily for week 1, 150 μg for weeks 2-4; vaginal progesterone 200 mg twice daily for weeks 3-4
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard hormone replacement treatment (sHRT) - oral ethinyloestradiol 30 μg and 1.5 mg norethisterone daily for weeks 1-3, week 4 'pill-free'
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Physiological sex steroid replacement (pSSR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard hormone replacement treatment (sHRT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 34
Study: 18204233

Group type: EXPERIMENTAL
Intervention: Cadaveric fascia lata (CFL) sling
Number of subjects: 139

Group type: COMPARATOR
Intervention: Intravaginal slingplasty (IVS)
Number of subjects: 139
Study: 16681888

Group type: EXPERIMENTAL
Intervention: HTG patients
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: NTG patients
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: HTG and NTG patients
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 219
Study: 12815872

Group type: EXPERIMENTAL
Intervention: Alcohol screening procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard procedures
Number of subjects: 0
Study: 10741933

Group type: EXPERIMENTAL
Intervention: Midazolam 35 microg/kg iv
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam 70 microg/kg iv
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo iv
Number of subjects: 60
Study: 9118628

Group type: EXPERIMENTAL
Intervention: Hard water (11-grain) with mild wash procedure
Number of subjects: 3

Group type: COMPARATOR
Intervention: Deionized water (0-grain) with mild wash procedure
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Exaggerated wash condition
Number of subjects: 3
Study: 1384335

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (n = 42)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Oxytocin (n = 45)
Number of subjects: 87
Study: 2876508

Group type: EXPERIMENTAL
Intervention: Intravenous administration of SMS 201-995 at doses of 25, 50, 100, and 200 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of SMS 201-995 at doses of 50, 100, 200, and 400 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both intravenous and subcutaneous administration of SMS 201-995
Number of subjects: 8
Study: 31948278

Group type: EXPERIMENTAL
Intervention: Ozanimod
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fingolimod
Number of subjects: 0
Study: 30360596

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the BASNEF model, delivered in three 45-minute sessions.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the BASNEF model.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 100
Study: 27267109

Group type: EXPERIMENTAL
Intervention: Physiotherapy informed by Acceptance and Commitment Therapy (PACT)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual physiotherapy care (UC)
Number of subjects: 240
Study: 23380274

Group type: EXPERIMENTAL
Intervention: Toothpaste containing 8% arginine and 1450 ppm mono‐fluorophosphate, a soft‐bristle toothbrush, mouthwash containing 0.8% arginine, PVM/MA copolymer, pyrophosphates, and 0.05% sodium fluoride
Number of subjects: 120

Group type: COMPARATOR
Intervention: Toothpaste containing 5% potassium nitrate and 1450 ppm sodium fluoride, a soft‐bristle toothbrush, mouthwash containing 0.51% potassium chloride and 230 ppm sodium fluoride
Number of subjects: 120

Group type: COMPARATOR
Intervention: Toothpaste containing 1450 ppm mono‐fluorophosphate, a soft‐bristle toothbrush, fluoride/arginine free mouthwash
Number of subjects: 120
Study: 22420119

Group type: EXPERIMENTAL
Intervention: Stage-tailored exercise behavior intervention based on the transtheoretical model
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 19194641

Group type: EXPERIMENTAL
Intervention: Osteoporosis Prevention and Self‐Management Course (OPSMC)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (wait list)
Number of subjects: 198
Study: 17971137

Group type: EXPERIMENTAL
Intervention: Hypodermoclysis (HDC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intravenous (i.v.) rehydration
Number of subjects: 9
Study: 15605213

Group type: EXPERIMENTAL
Intervention: Digital radiogrammetry (DXR)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Dual-energy X-ray absorptiometry (DXA)
Number of subjects: 153
Study: 11450148

Group type: EXPERIMENTAL
Intervention: Restoration of sinus rhythm
Number of subjects: 30
Study: 9508225

Group type: EXPERIMENTAL
Intervention: IV therapy team
Number of subjects: 0

Group type: COMPARATOR
Intervention: House staff
Number of subjects: 0
Study: 8002243

Group type: EXPERIMENTAL
Intervention: No ROP
Number of subjects: 1398

Group type: EXPERIMENTAL
Intervention: Less-than-prethreshold ROP
Number of subjects: 1398

Group type: EXPERIMENTAL
Intervention: Prethreshold ROP
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Threshold untreated ROP
Number of subjects: 1398
Study: 2927993

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo treatment (Control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (Girls)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (Boys)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (Boys and Girls combined)
Number of subjects: 50
Study: 31541635

Group type: EXPERIMENTAL
Intervention: 3.6-mL 2% lidocaine intracervical block
Number of subjects: 302

Group type: COMPARATOR
Intervention: Sham injection (intracervical dry-needling)
Number of subjects: 302

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 302
Study: 30661004

Group type: EXPERIMENTAL
Intervention: Standardized education package for PD training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pilot testing of the training modules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RCT planned for 2019
Number of subjects: 0
Study: 28370160

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided core needle biopsy (CNB) in patients undergoing antiplatelet/anticoagulation therapy
Number of subjects: 146

Group type: COMPARATOR
Intervention: Ultrasound-guided core needle biopsy (CNB) in patients not undergoing antiplatelet/anticoagulation therapy
Number of subjects: 146
Study: 25481918

Group type: COMPARATOR
Intervention: 21-mg nicotine patch
Number of subjects: 2326

Group type: EXPERIMENTAL
Intervention: 15-mg nicotine patch
Number of subjects: 2326
Study: 23805231

Group type: EXPERIMENTAL
Intervention: E-mails promoting the use of evidence-based self-help strategies
Number of subjects: 1736

Group type: COMPARATOR
Intervention: Control group receiving e-mails containing depression information
Number of subjects: 1736
Study: 21364138

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide gas
Number of subjects: 150

Group type: COMPARATOR
Intervention: Inhaled nitrogen placebo
Number of subjects: 150
Study: 19051207

Group type: EXPERIMENTAL
Intervention: Constrained longitudinal data analysis model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional longitudinal analysis of covariance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sample size formulas for longitudinal data analysis
Number of subjects: 0
Study: 22665104

Group type: EXPERIMENTAL
Intervention: Early invitation with MMS (multiple micronutrients including 30 mg of iron and 400 μg of folic acid)
Number of subjects: 4436

Group type: COMPARATOR
Intervention: Usual invitation with 60 mg of iron and 400 μg of folic acid
Number of subjects: 4436

Group type: EXPERIMENTAL
Intervention: Early invitation with MMS
Number of subjects: 4436

Group type: EXPERIMENTAL
Intervention: Early invitation
Number of subjects: 4436

Group type: COMPARATOR
Intervention: Usual invitation
Number of subjects: 4436

Group type: EXPERIMENTAL
Intervention: MMS (multiple micronutrients)
Number of subjects: 4436
Study: 16019621

Group type: EXPERIMENTAL
Intervention: 0.05% isotretinoin with sunscreens (SPF 15)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 346
Study: 12447213

Group type: EXPERIMENTAL
Intervention: Ovate pontic design with Super Floss cleaning once a day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control site (uncovered masticatory mucosal area)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ovate pontic design
Number of subjects: 12
Study: 9875300

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (BKCI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulfate (SLS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triethanolamine (TEA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tween 80
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BKCI, SLS, and Tween 80 (suction blister fluids)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TEA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BKCI and SLS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-1 alpha
Number of subjects: 0
Study: 8544154

Group type: EXPERIMENTAL
Intervention: Iso-osmotic bowel preparation (Klean Prep)
Number of subjects: 56

Group type: COMPARATOR
Intervention: 12 h starvation
Number of subjects: 56
Study: 2096198

Group type: EXPERIMENTAL
Intervention: KCl (75 mmol/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Potassium citrate (75 mmol/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 341949

Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0
Study: 28851508

Group type: EXPERIMENTAL
Intervention: Long-term housing subsidies
Number of subjects: 1857

Group type: COMPARATOR
Intervention: Usual care (no immediate referral to any intervention)
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: SSI/SSDI receipt
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Disabilities
Number of subjects: 1857
Study: 27365261

Group type: EXPERIMENTAL
Intervention: Non-immersive virtual reality using the Nintendo Wii gaming system (VRWii)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Recreational activities (playing cards, bingo, Jenga, or ball game)
Number of subjects: 141
Study: 24662398

Group type: EXPERIMENTAL
Intervention: evolocumab 140 mg Q2 W
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: evolocumab 420 mg QM
Number of subjects: 310

Group type: COMPARATOR
Intervention: placebo Q2 W or QM
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: evolocumab
Number of subjects: 310

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 310
Study: 23381198

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1000 mg intravenously during anesthesia induction)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no steroid administration)
Number of subjects: 30
Study: 19967328

Group type: EXPERIMENTAL
Intervention: Silicone spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18500478

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 15893523

Group type: EXPERIMENTAL
Intervention: Hearing language for spatial relations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Initial exposure to spatial terms
Number of subjects: 0